Background The 90-90-90 goal to achieve viral suppression in 90% of all human
immunodeficiency virus (HIV)–infected people on antiretroviral treatment (ART) is especially …

Background CD4 cell count has been identified to be an essential component in monitoring
HIV treatment outcome. However, CD4 cell count monitoring sometimes fails to predict …

Background The number of patients in need of second-line antiretroviral drugs is increasing
in sub-Saharan Africa. We aimed to project the need of second-line antiretroviral therapy in …

Vertical transmission accounts for most human immunodeficiency virus (HIV) infection in
children, and treatments for newborns are needed to abrogate infection or limit disease …

Introduction HIV viral load (VL) is accepted as a key biomarker in HIV transmission and
pathogenesis. This paper presents a review of the role of VL testing in mathematical models …

Background: Virologic and immunologic responses to antiretroviral treatment (ART) in
infants may differ from older children due to immunologic, clinical, or epidemiologic …

Introduction Antiretroviral therapy (ART) has been successfully introduced in low-middle
income countries. However an increasing rate of ART failure with resistant virus is reported …

Background The ease of access to antiretroviral therapy (ART) has improved both survival
rate and comorbidities in patients with human immunodeficiency virus (HIV) infection …

Abstract Background Many HIV-infected African children gained access to antiretroviral
treatment (ART) through expansion of PEPFAR programs since 2004 and introduction of …

The latest class of antiretrovirals (ARVs), including integrase strand transfer inhibitors
(INSTIs), has been demonstrated to be effective for antiretroviral therapy (ART). Despite all …